Firm News: Drugs & Devices: Page 11

Weitz & Luxenberg, P.C., is now accepting cases involving total hip arthroplasty patients who have been implanted with an OMNIlife science Apex K2 Modular Hip System hip implant. W&L began investigating these cases after reports of patient injuries appeared in medical journals. There was also a reported rate of revision in the Australian Orthopaedic Association…

W&L has begun looking into the dangers of using the TigerPaw System II during occlusion of the heart’s left atrial appendage, a procedure sometimes performed in patients with atrial fibrillation to prevent blood clots from collecting and traveling to other parts of the body. The firm has discovered reports regarding the closure device reported in…

W&L’s Paul Pennock was one of two court-appointed lead counsel on the Plaintiffs Steering Committee for the multidistrict litigation against drug manufacturer Takeda.

Attorney Richard J. Arsenault of Neblett, Beard & Arsenault, and Paul J. Pennock of Weitz & Luxenberg, were the court-appointed co-lead Plaintiffs’ counsel in the Multi-District Litigation (MDL 2299) pending in Lafayette, Louisiana.  This settlement relates to legal actions filed beginning in 2011 in response to Plaintiffs diagnosed with bladder cancer as a result of…